Back to OfferingsIntegrated delivery networks (IDNs) are often the most complicated, dissimilar, and least understood customer segment in healthcare, with a significant and growing impact on prescription drug utilization.
HMP MAI helps subscribers understand IDNs’ pharmaceutical management strategies and decision-making processes—in aggregate and at the account level. Our primary and secondary research illuminates IDNs' financial control practices, clinical oversight, and opportunities for engagement. In addition, our proprietary IDN archetyping methodology empowers our subscribers to successfully navigate this important segment.
